Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?
Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?
复制标题
DOI:
10.1016/j.bbrc.2016.09.053
复制
发表时间:
2017-02-19
影响因子:
3.1
通讯作者:
Bezprozvanny I
中科院分区:
文献类型:
--
作者:
Popugaeva E;Pchitskaya E;Bezprozvanny I
Alzheimer’s disease (AD) is the disease of lost memories. Synaptic loss is a major reason for memory defects in AD. Signaling pathways involved in memory loss in AD are under intense investigation. The role of deranged neuronal calcium (Ca2+) signaling in synaptic loss in AD is described in this review. Familial AD (FAD) mutations in presenilins are linked directly with synaptic Ca2+ signaling abnormalities, most likely by affecting endoplasmic reticulum (ER) Ca2+ leak function of presenilins. Excessive ER Ca2+ release via type 2 ryanodine receptors (RyanR2) is observed in AD spines due to increase in expression and function of RyanR2. Store-operated Ca2+ entry (nSOC) pathway is disrupted in AD spines due to downregulation of STIM2 protein. Because of these Ca2+ signaling abnormalities, a balance in activities of Ca2+-calmodulin-dependent kinase II (CaMKII) and Ca2+-dependent phosphatase calcineurin (CaN) is shifted at the synapse, tilting a balance between long-term potentiation (LTP) and long-term depression (LTD) synaptic mechanisms. As a result, synapses are weakened and eliminated in AD brains by LTD mechanism, causing memory loss. Targeting synaptic calcium signaling pathways offers opportunity for development of AD therapeutic agents.